Open
Actively Recruiting
Circulating CD8+ Cell Quantitation as a Predictive Marker of Prolactinoma Response to Dopamine-2 Agonist Therapy
About
Brief Summary
This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.
- If you need assistance with ClinicalTrials.gov registration for an oncology study, please contact the Jonsson Comprehensive Cancer Center's Office of Regulatory Compliance.
- If you need assistance with ClinicalTrials.gov registration for a non-oncology study, please contact the Office of Regulatory Affairs.
Eligibility
Minimum Age
Maximum Age
Join this Trial
Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
25-2251
Category
Endocrine and Metabolic Disorders
Principal Investigator
Contact
- Cristian Santana
Location
- UCLA Westwood